Shen M, Mao Y, Wang X, Huang J, Zhang Q, Zhang J
Sci Rep. 2024; 14(1):31502.
PMID: 39732940
PMC: 11682247.
DOI: 10.1038/s41598-024-83170-4.
Wangpu X, Zhao J, Yu C, Yu S, Wang H, Yuan Z
Am J Cancer Res. 2023; 13(11):5610-5625.
PMID: 38058810
PMC: 10695776.
Pattnaik B, Negi V, Chaudhuri R, Desiraju K, Faizan M, Akhtar A
Cell Mol Life Sci. 2023; 80(12):357.
PMID: 37950757
PMC: 11072886.
DOI: 10.1007/s00018-023-05005-1.
Yang J, Lee I, Huang C, Huang H, Wu Y, Chong Z
Int J Mol Sci. 2023; 24(9).
PMID: 37175410
PMC: 10178422.
DOI: 10.3390/ijms24097703.
Ju H, Kim B, Lim I, Byun B, Woo S
Int J Mol Sci. 2023; 24(3).
PMID: 36769108
PMC: 9917349.
DOI: 10.3390/ijms24032794.
The miRNA125a-5p and miRNA125b-1-5p cluster induces cell invasion by down-regulating DDB2-reduced epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Zhu F, Wei J, He D, He J, Liu L, Hou H
J Gastrointest Oncol. 2023; 13(6):3112-3122.
PMID: 36636074
PMC: 9830343.
DOI: 10.21037/jgo-22-1222.
Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer.
Zou K, Yang E, Cui T, Li Z
Front Oncol. 2022; 12:1036710.
PMID: 36439477
PMC: 9682073.
DOI: 10.3389/fonc.2022.1036710.
The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer.
Kipkeeva F, Muzaffarova T, Korotaeva A, Mansorunov D, Apanovich P, Nikulin M
Int J Mol Sci. 2022; 23(16).
PMID: 36012588
PMC: 9409052.
DOI: 10.3390/ijms23169324.
Hsa_circ_0020850 promotes the malignant behaviors of lung adenocarcinoma by regulating miR-326/BECN1 axis.
Li X, Su S, Ye D, Yu Z, Lu W, Liu L
World J Surg Oncol. 2022; 20(1):13.
PMID: 35012553
PMC: 8750879.
DOI: 10.1186/s12957-021-02480-3.
ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress.
Adu-Amankwaah J, Adzika G, Adekunle A, Ndzie Noah M, Mprah R, Bushi A
Front Cell Dev Biol. 2021; 9:732952.
PMID: 34966735
PMC: 8710811.
DOI: 10.3389/fcell.2021.732952.
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.
Aslani M, Mortazavi-Jahromi S, Mirshafiey A
Int Immunopharmacol. 2021; 101(Pt A):108172.
PMID: 34601331
PMC: 8452524.
DOI: 10.1016/j.intimp.2021.108172.
The Synergy of ADAM17-Induced Myocardial Inflammation and Metabolic Lipids Dysregulation During Acute Stress: New Pathophysiologic Insights Into Takotsubo Cardiomyopathy.
Adu-Amankwaah J, Adzika G, Adekunle A, Ndzie Noah M, Mprah R, Bushi A
Front Cardiovasc Med. 2021; 8:696413.
PMID: 34150874
PMC: 8212952.
DOI: 10.3389/fcvm.2021.696413.
Strategies to Target ADAM17 in Disease: From its Discovery to the iRhom Revolution.
Calligaris M, Cuffaro D, Bonelli S, Spano D, Rossello A, Nuti E
Molecules. 2021; 26(4).
PMID: 33579029
PMC: 7916773.
DOI: 10.3390/molecules26040944.
TMPO-AS1, a Novel E2F1-Regulated lncRNA, Contributes to the Proliferation of Lung Adenocarcinoma Cells via Modulating miR-326/SOX12 Axis.
Wei L, Liu Y, Zhang H, Ma Y, Lu Z, Gu Z
Cancer Manag Res. 2020; 12:12403-12414.
PMID: 33293866
PMC: 7719338.
DOI: 10.2147/CMAR.S269269.
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth.
Miele E, Po A, Mastronuzzi A, Carai A, Besharat Z, Pediconi N
Mol Oncol. 2020; 15(2):523-542.
PMID: 32920979
PMC: 7858128.
DOI: 10.1002/1878-0261.12800.
Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
Guo Y, He X, Zhang M, Qu Y, Gu C, Ren M
J Neurooncol. 2020; 147(2):327-337.
PMID: 32170633
DOI: 10.1007/s11060-020-03453-4.
MiR-326: Promising Biomarker for Cancer.
Pan Y, Wan J, Wang C
Cancer Manag Res. 2019; 11:10411-10418.
PMID: 31849530
PMC: 6912009.
DOI: 10.2147/CMAR.S223875.
Novel Therapeutic Anti-ADAM17 Antibody A9(B8) Enhances EGFR-TKI-Mediated Anticancer Activity in NSCLC.
Yang Z, Chan K, Kwok H, Tam K
Transl Oncol. 2019; 12(11):1516-1524.
PMID: 31450127
PMC: 6717059.
DOI: 10.1016/j.tranon.2019.08.003.
ADAM17: An Emerging Therapeutic Target for Lung Cancer.
Saad M, Rose-John S, Jenkins B
Cancers (Basel). 2019; 11(9).
PMID: 31438559
PMC: 6769596.
DOI: 10.3390/cancers11091218.
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition.
Xu S, Lam S, Cheng P, Ho J
Sci Rep. 2019; 9(1):12030.
PMID: 31427725
PMC: 6700313.
DOI: 10.1038/s41598-019-48476-8.